Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

KORU Medical Systems (KRMD) EBITDA (2020 - 2025)

Historic EBITDA for KORU Medical Systems (KRMD) over the last 11 years, with Q3 2025 value amounting to -$867679.0.

  • KORU Medical Systems' EBITDA rose 4119.47% to -$867679.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.0 million, marking a year-over-year increase of 3720.57%. This contributed to the annual value of -$6.4 million for FY2024, which is 3723.23% up from last year.
  • Latest data reveals that KORU Medical Systems reported EBITDA of -$867679.0 as of Q3 2025, which was up 4119.47% from -$312655.0 recorded in Q2 2025.
  • KORU Medical Systems' EBITDA's 5-year high stood at -$312655.0 during Q2 2025, with a 5-year trough of -$3.5 million in Q2 2022.
  • Moreover, its 5-year median value for EBITDA was -$1.6 million (2023), whereas its average is -$1.8 million.
  • In the last 5 years, KORU Medical Systems' EBITDA crashed by 42228.72% in 2021 and then surged by 6790.55% in 2025.
  • Quarter analysis of 5 years shows KORU Medical Systems' EBITDA stood at -$2.1 million in 2021, then dropped by 18.85% to -$2.5 million in 2022, then increased by 12.5% to -$2.2 million in 2023, then rose by 27.67% to -$1.6 million in 2024, then soared by 45.41% to -$867679.0 in 2025.
  • Its EBITDA was -$867679.0 in Q3 2025, compared to -$312655.0 in Q2 2025 and -$1.2 million in Q1 2025.